The global diagnostic kits market is experiencing significant growth, driven by rising demand for disease detection kits, increasing prevalence of chronic and infectious diseases, and the growing adoption of point-of-care diagnostics. In 2024, the market for medical diagnostic kits and laboratory testing solutions was estimated at approximately USD 45.2 billion, expanding at a CAGR of around 7.1%. Advancements in molecular diagnostic kits, immunoassay kits, and PCR kits, alongside high demand for COVID-19 test kits, are fueling adoption. The diagnostic kits industry encompasses a wide range of offerings, including rapid diagnostic kits, in-vitro diagnostic kits, blood testing kits, diagnostic reagents, and portable diagnostic kits, supporting disease detection, diagnostic monitoring, and healthcare diagnostics. Product segmentation includes clinical diagnostic kits, diagnostic assays, diagnostic screening kits, and home diagnostic kits, addressing needs in diagnostic accuracy, disease monitoring kits, and advanced diagnostic applications. Diagnostic kits industry growing innovation in diagnostic sensors, diagnostic software, and diagnostic platform solutions is enhancing efficiency, diagnostic performance, and workflow integration in hospitals, laboratories, and home-care settings. The surge in diagnostic innovations is driving development in diagnostic technology, laboratory diagnostic systems, and point-of-care testing solutions, enabling faster turnaround times and improved healthcare outcomes.
Diagnostic Kits overview
Published by MMR Statistics Research Team, Updated